Project Details
Description
An open-label, multicenter study in male pediatric patients with cerebral x-linked adrenoleukodystrophy (cald) to assess the effects of min-102 treatment on disease progression prior to human stem cell transplant (hsct)
| Status | Finished |
|---|---|
| Effective start/end date | 8/22/19 → 7/1/21 |
Funding
- MINORYX THERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.